Sfoglia per Autore
Bullous, cutaneous, pleomorphic T-cell Lymphoma: analysis of integrins and extracellular matrix components.
1996-01-01 SAVOIA P; NOVELLI M; FIERRO MT; BERNENGO MG
CD3-CD56+ primary pure cutaneous lymphoma: a distinct entity in the spectrum of CD56 malignancies.
1996-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
Skin infiltrating lymphocyte flow-cytometric immunophenotyping: automated mechanical biopsy disaggregation and CD45 gating.
1996-01-01 Novelli M; Fierro MT; Lisa F; De Matteis A; Quaglino P; Savoia P; Verrone A; Cambieri I; Bernengo MG
Espressione del CD26 sui cheratinociti in patologie cutanee, infiammatorie e neoplastiche.
1995-01-01 Novelli M; Verrone A; Savoia P; Fierro MT; Santoro V
Effectiveness of low doses integrated chemo-immuno-hormonotherapy for advanced metastatic melanoma.
1995-01-01 Bernengo MG; Doveil GC; Bertero M; Fierro MT; Quaglino P.
Interleuchina-2 (IL-2) a basse dosi per via sottocutanea associata a chemio-immuno-ormonoterapia nel trattamento del melanoma in stadio IV.
1995-01-01 Doveil GC; Bertero M; Fierro MT; Colonna S; Appino A; Quaglino P; Savoia P; Bernengo MG
KM-93 expression on peripheral blood lymphocytes (PBL) in inflammatory skin diseases, mycosis fungoides and Sézary syndrome.
1995-01-01 Quaglino P; Fierro MT; Savoia P; Novelli M; Lisa F; Bernengo MG:
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei
1995-01-01 Doveil GC; Fierro MT; Appino A; Quaglino P; Savoia P
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
Clinical presentation and immunological features of an Italian ATL case
1995-01-01 FIERRO MT; SAVOIA P; NOVELLI M; GHISETTI V; LISA F; BERNENGO MG
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance
1995-01-01 DOVEIL GC; FIERRO MT; M. NOVELLI; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
KM-93 expression on peripheral blood lymphocytes (PBL) in inflammatory skin diseases, mycosis fungoides and Sézary syndrome.
1995-01-01 Quaglino P; Fierro MT; Savoia P; Novelli M; Lisa F; Bernengo MG
IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
1995-01-01 GUARINI A ;GANSBACHER B ;CRONIN K ;FIERRO MT ;FOA R
Un caso di leucemia/linfoma a cellule T dell'adulto con localizzazioni cutanee: caratteristiche cliniche, istologiche ed immunologiche
1995-01-01 Savoia P; Fierro MT; Novelli M
The association of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma (CTCL).
1995-01-01 Bernengo MG; Doveil GC; Fierro MT; Quaglino P; Savoia P:
Prognostic factors in Sézary syndrome.
1994-01-01 Bernengo MG; Novelli M; Appino A; Quaglino P; Savoia P; Fierro MT
CD26 (DPP-IV)- A useful marker in Sezary sindrome
1994-01-01 Novelli M; Fierro MT; Quaglino P; Lisa F; Doveil GC; Bernengo MG
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile